Before the emergence of data from the SUNLIGHT trial, there were only 2 options for therapy in advanced colorectal cancer: ...

DelveInsight’s, “Metastatic Colorectal Cancer Pipeline Insight 2025” report provides comprehensive insights about 150+ ...

Pharming receives positive recommendation from NICE for Joenja®▼(leniolisib) as a treatment for APDS Joenja® is the first and only medicine specifically for APDS to be reimbursed within the ...

Leiden, the Netherlands Thursday, April 24, 2025, 10:00 Hrs [IST] ...

In a study published in Angewandte Chemie International Edition, a research team integrated activity-based protein profiling ...

Compared with DPP4 inhibitors, SGLT2 inhibitors reduce the risk for kidney and ureteral stones in patients with type 2 diabetes, including those with a stone history. Sodium-glucose cotransporter 2 ...

In Alzheimer's, Parkinson's, and type 2 diabetes, harmful protein aggregates and deposits, known as amyloid plaques, develop.

The continued success of abelacimab throughout the AZALEA-TIMI 71 trials helps draw the drug closer to FDA approval, stated ...

Doctors might be able to use a new scoring system to avoid unnecessary surgery to prevent strokes, a new study shows.

An investigational monoclonal antibody called bentracimab can safely and effectively reverse potentially catastrophic bleeding complications linked to ticagrelor, a common drug used to treat patients ...

Participants with uncontrolled and otherwise treatment-resistant hypertension showed significant blood pressure improvement ...

An Israeli study has identified TRIM63 as a significant genetic contributor to hypertrophic cardiomyopathy (HCM)—the most ...